← Back
$DTIL All transactions

PRECISION BIOSCIENCES INC

▼ SELL 10b5-1 Plan

$ Value

$8K

Shares

1,303

Price

$6

Filed

Nov 4

Insider

Name

Kelly John Alexander

Title

Chief Financial Officer

CIK

0001590030

Roles

Officer

Transaction Details

Transaction Date

2025-11-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

77,298

Footnotes

Represents the vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2025. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | Includes 1,511 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a price of $4.17 | The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.

Filing Info

Accession No.

0001628280-25-048858

Form Type

4

Issuer CIK

0001357874

Kelly John Alexander's History

Date Ticker Type Value
2026-02-18 DTIL $31K
2026-02-17 DTIL M $0
2026-02-17 DTIL M $0
2026-01-21 DTIL $61K
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0

Other Insiders at DTIL (90d)

Insider Bought Sold Last
Kelly John Alexander
Chief Financial Officer
$31K 2026-02-18
SMITH J. JEFFERSON
Chief Research Officer
$19K 2026-02-18
Scimeca Dario
General Counsel and Secretary
$19K 2026-02-18
Amoroso Michael
President and CEO
$79K 2026-02-18